drugset / Trial / NCT01452997

Evaluation of Anti-inflammatories in the Reduction of Bite Reactions

NCT01452997

Phase 4 Completed 40 enrolled London School of Hygiene and Tropical Medicine
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate two separate antiinflammatory products for the relief of symptoms through suppression of the immunological and inflammatory response following a mosquito bite. The investigators have selected ibuprofen gel as a NSAI formulation and 0.05% Clobetasone butyrate as a steroid cream with their appropriate physical matched placebo products.

Timeline

Start
2012-11
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clobetasone Butyrate Small molecule 0.05 % Topical
Comparator Ibuprofen Small molecule 5 % Topical

Indications

No indication recorded.